181 related articles for article (PubMed ID: 23384023)
1. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
Broshtilova V; Iliev E; Gantcheva M
Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
[TBL] [Abstract][Full Text] [Related]
2. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
Mukhtyar C; Luqmani R
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rheumatoid arthritis with etanercept.
Genovese MC; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
[TBL] [Abstract][Full Text] [Related]
4. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
Kekow J; Welte T; Kellner U; Pap T
Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
[No Abstract] [Full Text] [Related]
5. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Watson P; Simler N; Screaton N; Lillicrap M
Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
[No Abstract] [Full Text] [Related]
6. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
[No Abstract] [Full Text] [Related]
8. Etanercept-associated right abducens nerve palsy in rheumatoid arthritis.
Lai CC; Hsiao KH; Chang YS; Tsai CY; Chou CT
Int J Rheum Dis; 2012 Oct; 15(5):e117-9. PubMed ID: 23083045
[No Abstract] [Full Text] [Related]
9. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
Uthman I; Husari A; Touma Z; Kanj SS
Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
[No Abstract] [Full Text] [Related]
10. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.
Lindsay K; Melsom R; Jacob BK; Mestry N
Rheumatology (Oxford); 2006 Aug; 45(8):1048-9. PubMed ID: 16760195
[No Abstract] [Full Text] [Related]
11. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
12. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
Lai-Cheong J; Warren R; Bucknall R; Parslew R
J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
[No Abstract] [Full Text] [Related]
13. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
Duffy TN; Genta M; Moll S; Martin PY; Gabay C
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
[No Abstract] [Full Text] [Related]
14. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
[No Abstract] [Full Text] [Related]
16. Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept.
Asahina A; Ohshima N; Nakayama H; Shirai A; Juji T; Matsui T
Eur J Dermatol; 2010; 20(4):521-2. PubMed ID: 20413370
[No Abstract] [Full Text] [Related]
17. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
19. Etanercept-associated SLE with lupus nephritis.
Neradová A; Stam F; van den Berg JG; Bax WA
Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
[No Abstract] [Full Text] [Related]
20. Drug-induced systemic lupus erythematosus associated with etanercept therapy.
Shakoor N; Michalska M; Harris CA; Block JA
Lancet; 2002 Feb; 359(9306):579-80. PubMed ID: 11867114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]